Sermorelin was previously FDA-approved under the brand name Geref, both as a diagnostic agent for GH deficiency (Geref Diagnostic, approved 1997) and as a therapeutic agent for pediatric idiopathic GH deficiency
That said, it wont have full approval until late 2026, possibly even 2027
The added glucagon-receptor activity of GLP-3 RT is associated in research with stronger effects on energy expenditure, hepatic lipid handling, and metabolic rate
Studies in human and animal models suggest that GLP-1 may play a role in lipid metabolism and obesity
For more details on how semaglutide works in your body , understanding the pharmacokinetics helps explain why doubling is both unnecessary and risky
If you are using a liposomal liquid, you can take it directly or mix it into a small amount of water or juice